Guidant Corp.

Recent Events

News & Analysis

guidant corp. and physician - All News and Analysis

• Guidant Announces Updated and Positive Results of Real-World Carotid Artery Stenting Study; Results from 2,500 Patients Suggest Therapy Can Be Performed Safely by Broad Group of Physicians

  - 2006-03-14

  INDIANAPOLIS & ATLANTA -- Guidant Corporation (NYSE:GDT) today announced updated results of 2,500 patients enrolled in its post approval study of carotid artery stenting, called CAPTURE (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events). Results were presented today during the Late Breaking Registry Session at the American College of...

  Tags: Guidant Corp., patient, physician, therapy

• Guidant Updates Worldwide Physician Communication Regarding Important Safety Information About Certain Pacemakers

  - 2006-01-23

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) is voluntarily advising and updating physicians about important safety information regarding certain older model pacemakers. This communication advises physicians about potential unanticipated device behaviors and is intended to limit adverse events. Physicians should use this information to decide how best to treat their patients.

  Tags: Guidant Corp., physician

• Guidant Announces European Approval of Innovative Heart Failure Lead; Advanced Lead is Designed to Enable Physicians to Overcome Challenging Left Ventricular Anatomy

  - 2005-12-12

  INDIANAPOLIS & ST. PAUL, Minn. -- Guidant Corporation (NYSE:GDT) today announced Conformite Europeenne CE Mark approval of its ACUITYR Steerable heart failure lead. This product is Guidant's latest left ventricular LV lead designed to help physicians reach the goal of performing fast and predictable implants.

  Tags: Guidant Corp., physician

• Guidant Announces Positive Preliminary Results of Large Real-World Carotid Artery Stenting Study; Study Suggests Therapy Can Be Performed Safely by Broad Group of Physicians

  - 2005-10-20

  INDIANAPOLIS & WASHINGTON -- Guidant Corporation (NYSE:GDT) today announced preliminary results of its study of carotid artery stenting in high-risk patients, called CAPTURE (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events). Results were presented today during the Late Breaking Registry Session at the Transcatheter Cardiovascular Therapeutics meeting in Washington,...

  Tags: Guidant Corp., physician, therapy

• Guidant Announces FDA Approval of New Implantable Defibrillator System; High Energy System Addresses Growing Physician Demand for More Defibrillation Energy

  - 2005-09-30

  INDIANAPOLIS & ST. PAUL, Minn. -- Guidant Corporation (NYSE:GDT) today announced U.S. Food and Drug Administration FDA market approval of its VITALITYR HE implantable cardioverter defibrillator. This system combines the small, physiologic profile and exceptional longevity with the capacity to deliver more energy to defibrillate the patient. In addition, the...

  Tags: Guidant Corp., physician, Vitality

• Guidant Initiates Voluntary Physician Advisory on Certain Pacemakers

  - 2005-09-22

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) said today that it is informing physicians about two separate failure modes, each occurring at a low rate, being monitored within the INSIGNIAR and NEXUSR families of Guidant implantable pacemakers. Physicians should use this information to decide how best to treat their patients.

  Tags: Guidant Corp., physician

• Guidant Initiates Worldwide Physician Communications Regarding Important Safety Information and Corrective Action about Certain Pacemakers

  - 2005-07-18

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) said today it is voluntarily advising physicians about important safety information regarding certain devices. Guidant apprised FDA of this action, and FDA may classify this action as a recall. This communication advises physicians and their patients of safety information and is intended to limit adverse...

  Tags: Guidant Corp., physician

• FDA Classifies Prior Guidant Recalls; Guidant Reiterates its Previous Physician and Patient Recommendations

  - 2005-07-01

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) said today that FDA has classified its June 17, 2005 and June 24, 2005 physician communications regarding certain devices.

  Tags: FDA, Guidant Corp., patient, physician

• Guidant Initiates Worldwide Physician Communications Regarding Important Safety Information and Corrective Action about Implantable Cardiac Defibrillators

  - 2005-06-24

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) said today it is voluntarily advising physicians about important safety information regarding certain devices. Guidant apprised FDA of this action, and FDA may classify this action as a recall. At this time, Guidant is in the very early stages of a diligent evaluation of the...

  Tags: Guidant Corp., physician

• Guidant Requests Independent Panel to Recommend Physician and Patient Communication Guidelines

  - 2005-06-22

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) today announced its intention to establish an independent panel of experts to recommend guidelines for when to disseminate information to physicians and patients about life-sustaining implantable devices.

  Tags: Guidant Corp., patient, physician